ArtBio
Cambridge, United States · Founded 2021 · $132.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- artbio.com
- Total Funding
- $132.0M
- Last Round
- $132.0M Series BJul 2025
- Rounds
- 1
About
Clinical-stage radiopharmaceutical biotech developing alpha radioligand therapies for cancer, founded in 2021 and headquartered in Cambridge, Massachusetts.
Summary
ArtBio is a Biotech company based in Cambridge, United States, founded in 2021. It has raised $132.0M in total across 1 round, most recently a $132.0M Series B round in Jul 2025.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2025
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...